课题基金 / 基金详情

qHTS to Identify Activators and Inhibitors of Wip1

qHTS to Identify Activators and Inhibitors of Wip1
qHTS 鉴定 Wip1 激活剂和抑制剂
批准号:
10004989
负责人:
Matthew Hall
金额:
$4.76万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Matthew Hall的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的总体目标是开发有效的,选择性的和生物活性的Wip1小分子调节剂,用作化学探针和治疗开发的起点。 在此期间,项目团队开发并验证了适合高通量筛选的Wip1活性测定。Wip1活性测定通过NCATS药物收集的定量高通量筛选进行验证。经验证的检测方法正用于高通量筛选整个NCATS收集的小分子。其他基于细胞的活性测定也得到了优化和验证。额外的努力集中在酶作用机制的详细机理研究上,这可以在化学先导物的药物化学优化期间利用。
英文摘要
The overall objective of this project is to develop potent, selective, and bioactive small molecule modulators of Wip1 for use as chemical probes and starting points for therapeutic development. During this period, the project team developed and validated a Wip1 activity assay amenable for high-throughput screening. The Wip1 activity assay was validated by quantitative high-throughput screening of the NCATS pharmaceutical collection. The validated assay is being used for high-throughput screening of the entire NCATS collection of small molecules. Other cell-based activity assays have also been optimized and validated. Additional efforts have focused on detailed mechanistic studies of the enzymes mechanism of action, which could be exploited during medicinal chemistry optimization of chemical leads.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BRD4 Inhibitors as Potential Therapeutics for Oncology
qHTS to Identify Inhibitors of Mutant and Wildtype NSD2
qHTS to Identify Activators and Inhibitors of Wip1
qHTS to Identify Inducers of Oligodendrocyte-precursor cell (OPC) Remyelination
海外基金